As a first or corresponding author in international journals: 42 articles (as of Mar 2018)
1.Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis. Park JH, Ovbiagele B, Hong KS, Kwon SU. J Stroke. 2017 Sep;19(3):304-311
2.Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial. Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH; Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group. JAMA Neurol. 2017 Oct 1;74(10):1206-1215
3. Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study. Hong KS, Kim YK, Bae HJ, Nam HS, Kwon SU, Bang OY, Cha JK, Yoon BW, Rha JH, Lee BC, Park JM, Park MS, Lee J, Choi JC, Kim DE, Lee KB, Park TH, Lee JS, Kim SE, Lee J. J Clin Neurol. 2017 Jul;13(3):273-280.
4. Blood Pressure Management for Stroke Prevention and in Acute Stroke. Hong KS. J Stroke. 2017 May;19(2):152-165.
5. Endovascular Therapy: The Second Round Begins.Lee JS, Hong KS. J Stroke. 2017 May;19(2):119-120.
6. Simple estimates using age and stroke severity for intracranial hemorrhage and outcome after intravenous thrombolysis. Hye Jung Lee, Ji Sung Lee, Jay Chol Choi, Yong-Jin Cho, Beom Joon Kim, Hee-Joon Bae, Dong-Eog Kim, Wi-Sun Ryu, Jae-Kwan Cha, Dae Hyun Kim, Hyun-Wook Nah, Kang-Ho Choi, Joon-Tae Kim, Man-Seok Park, Jeong-Ho Hong, Sung Il Sohn, Kyusik Kang, Jong-Moo Park, Wook-Joo Kim, Jun Lee, Dong-Ick Shin, Min-Ju Yeo, Kyung Bok Lee, Jae Guk Kim, Soo Joo Lee, Byung-Chul Lee, Mi Sun Oh, Kyung-Ho Yu, Tai Hwan Park, Juneyoung Lee, Keun-Sik Hong. J Stroke 2017 In press
7. Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis. Choi JC, Lee JS, Park TH, Cho YJ, Park JM, Kang K, Lee KB, Lee SJ, Kim JG, Lee J, Park MS, Choi KH, Kim JT, Yu KH, Lee BC, Oh MS, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Kim BJ, Bae HJ, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee J, Hong KS. J Stroke. 2016 Sep;18(3):344-351.
8. Recurrent Ischemic Lesions after Acute Atherothrombotic Stroke: Clopidogrel plus Aspirin vs. Aspirin alone. Keun-Sik Hong, Seung-Hoon Lee, Eung Gyu Kim, Ki-Hyun Cho, Dae Il Chang, Joung-Ho Rha, Hee-Joon Bae, Kyung Bok Lee, Dong Eog Kim, Jong-Moo Park, Hahn-Young Kim, Jae-Kwan Cha, Kyung-Ho Yu, Yong-Seok Lee, Soo Joo Lee, Jay Chol Choi, Yong-Jin Cho, Sun U. Kwon, Gyeong-Moon Kim, Sung-Il Sohn, Kwang-Yeol Park, Dong-Wha Kang, Chul-Ho Sohn, Jun Lee, Byung-Woo Yoon. Stroke 2016 Sep;47(9):2323-30
9. Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke. Keun-Sik Hong, Sang-Bae Ko, Kyung-Ho Yu, Cheolkyu Jung, Sukh Que Park, Byung Moon Kim, Chul-Hoon Chang, Hee-Joon Bae, Ji Hoe Heo, Chang Wan Oh, Byung-Chul Lee, Bum-Tae Kim, Bum-soo Kim, Chin-Sang Chung, Byung-Woo Yoon, Joung-Ho Rha. J Stroke. 2016;18(1):102-113.
10. Recurrent Stroke, Myocardial Infarction, and Major Vascular Events during the First Year after Acute Ischemic Stroke: The Multicenter Prospective Observational Study about Recurrence and Its Determinants after Acute Ischemic Stroke I. Kang K, Park TH, Kim N, Jang MU, Park SS, Park JM, Ko Y, Lee S, Lee KB, Lee J, Kim DE, Cho YJ, Kim JT, Kim DH, Cha JK, Han MK, Lee JS, Lee J, Oh MS, Choi JC, Lee BC, Hong KS, Bae HJ. J Stroke Cerebrovasc Dis.
11. Rationale and Design of PreventIon of Cardiovascular events in iSchemic Stroke patients with high risk of cerebral hemorrhage (PICASSO) study; a randomized controlled trial. Hong KS, BJ Kim, J Lee, SU Kwon. Int J Stroke 2015;10:1153-8.
12. Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. JC Choi, JS Lee, TH Park, YJ Cho, JM Park, K Kang, KB Lee, SJ Lee, Y Ko, J Lee, JT Kim, KH Yu, BC Lee, JK Cha, DH Kim, J Lee, DE Kim, MS Jang, BJ Kim, MK Han, HJ Bae, KS Hong. BMC Neurol. 2015 Jul 30;15:120. doi: 10.1186/s12883-015-0376-3.
13. Intravenous tissue plasminogen activator improves the outcome in very elderly Korean patients with acute ischemic stroke. JC Choi, JS Lee, TH Park, SS Park, YJ Cho, JM Park, K Kang, KB Lee, SJ Lee, Y Ko, JG Kim, J Lee, KH Cho, JT Kim, KH Yu, BC Lee, MS Oh, JK Cha, DH Kim, HW Nah, DE Kim, WS Ryu, BJ Kim, HJ Bae, WJ Kim, DI Shin, MJ Yeo, SI Sohn, JH Hong, J Lee, KS Hong. J Stroke 2015;17(3):327-335.
14. Dabigatran effect on left ventricular thrombus in a patient with acute ischemic stroke. K Chung, YM Paek, HJ Lee, KS Hong. J Stroke 2015;17(3):366-368.
15. Statins in Acute Ischemic Stroke: Systematic Review. Hong KS, JS Lee. J Stroke 2015;17(3):282-301.
16. Endovascular Recanalization Therapy in Acute Ischemic Stroke: Updated Meta-analysis of Randomized Controlled Trials. Keun-Sik Hong, Sang-Bae Ko, Ji Sung Lee, Kyung-Ho Yu, Joung-Ho Rha. J Stroke 2015;17(3):268-81.
17. Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation. Hong KS, Choi YJ, Kwon SU; Triple AXEL Investigators. Int J Stroke. 2015 Jan;10(1):128-33.
18. Trends in yield of a code stroke program for enhancing thrombolysis. Kim A, Lee JS, Kim JE, Paek YM, Chung K, Park JH, Cho YJ, Hong KS. J Clin Neurosci. 2015;22(1):73-8.
19. Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons. Keun-Sik Hong. J Clin Neurol. 2014;10(3);189-196.
20. Safety and Efficacy of Intravenous Recombinant Tissue Plasminogen Activator Administered in the 3- to 4.5-hour Window in Korea. Tai Hwan Park, Ji Sung Lee, Sang-Soon Park, Youngchai Ko, Soo Joo Lee, Kyung Bok Lee, Jun Lee, Kyusik Kang, Jong-Moo Park, Jay Chol Choi, Dong-Eog Kim, Yong-Jin Cho, Joon-Tae Kim, Dae-Hyun Kim, Jae-Kwan Cha, Moon-Ku Han, Juneyoung Lee, Mi Sun Oh, Kyung-Ho Yu, Byung-Chul Lee, Hee-Joon Bae, Keun-Sik Hong. J Stroke Cerebrovasc Dis. 2014 Aug;23(7):1805-12.
21. Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis. Cho JY, Hong KS, Kim HJ, Kim SH, Min JH, Kim NH, Ahn SW, Park MS, An JY, Kim BJ, Kim W. Mult Scler. 2014;20(9):1217-1223.
22. Statin Preion Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack. Hong KS, Oh MS, Choi HY, Cho AH, Kwon HM, Yu KH, Bae HJ, Lee J, Lee BC; ROLLERKOST Study Group. J Clin Neurol. 2013 Oct;9(4):214-22.
23. Greater stroke severity predominates over all other factors for the worse outcome of cardioembolic stroke. Keun-Sik Hong, Juneyoung Lee, Hee-Joon Bae, Ji Sung Lee, Dong-Wha Kang, Kyung-Ho Yu, Moon-Ku Han, Yong-Jin Cho, Pamela Song, Jong-Moo Park, Mi-Sun Oh, Jaseong Koo, Byung-Chul Lee. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e373-80.
24. Validation of Minor Stroke Definitions for Thrombolysis Decision Making. Tai Hwan Park, Keun-Sik Hong, Jay Chol Choi, Pamela Song, Ji Sung Lee, Juneyoung Lee, Jong-Moo Park, Kyusik Kang, Kyung Bok Lee, Yong-Jin Cho, Gustavo Saposnik, Moon-Ku Han, Hee-Joon Bae. Journal of Stroke & Cerebrovascular Diseases. 2013: 22 (4): 482-490.
25. Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center for Stroke. Keun-Sik Hong, Oh Young Bang, Jong S. Kim, Ji Hoe Heo, Kyung-Ho Yu, Hee-Joon Bae, Dong-Wha Kang, Jin Soo Lee, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Byung-Woo Yoon. Journal of Stroke. 2013;15:67-77.
26. Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke. Keun-Sik Hong, Oh Young Bang, Dong-Wha Kang, Kyung-Ho Yu, Hee-Joon Bae, Jin Soo Lee, Ji Hoe Heo, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Jong S. Kim, Byung-Woo Yoon. Journal of Stroke. 2013;15:2-20.
27. Efficacy and safety of thrombolysis in patients aged 80 years or above with major acute ischemic stroke. Kim SC, Hong KS, Cho YJ, Cho JY, Park HK, Song P. Neurol India. 2012 Jul-Aug;60(4):373-8.
28. Safety and efficacy of mechanical thrombectomy with the Solitaire device in large artery occlusion. Kim JE, Kim AR, Paek YM, Cho YJ, Lee BH, Hong KS. Neurol India. 2012 Jul-Aug;60(4):400-5.
29. Declining Stroke and Vascular Event Recurrence Rates in Secondary Prevention Trials over the Past 50 Years and Consequences for Current Trial Design. Hong KS, Yegiaian S, Lee M, Lee J, Saver JL. Circulation 2011;123:2111-2119.
30. Weighting Components of Composite Endpoints in Clinical Trials: An Approach Employing Disability Adjusted Life Years. Hong KS, Ali K, Selco SL, Fonarow GC, Saver JL. Stroke 2011;42:1722-9.
31. Disability-Adjusted Life Years (DALY) analysis: Implications for stroke research. Hong KS. J Clin Neurol. 2011:7;109-114.
32. Burden of Ischemic Stroke in Korea: Disability-Adjusted Life Years (DALY) lost Analysis. Hong KS, Kim J, Cho YJ, Seo SY, Hwang SI, Kim SC, Kim JE, Cho JY, Park HK, Bae HJ, Yang MH, Jang MS, Han MK, Lee J, Kang DW, Park JM, Koo J, Yu KH, Oh MS, Lee BC. J Clin Neurol. 2011;7:77-84.
33. Years of Optimum Health Lost Due to Complications After Acute Ischemic Stroke. Disability-Adjusted Life-Years Analysis. Hong KS, Saver JL, Kang DW, Bae HJ, Yu KH, Koo J, Han MK, Cho YJ, Park JM, Lee BC. Stroke. 2010 Aug;41(8):1758-65.
34. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Hong KS, Saver JL. Stroke. 2010 Mar;41(3):471-7.
35. Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial. Hong KS, Kang DW, Bae HJ, Kim YK, Han MK, Park JM, Rha JH, Lee YS, Koo JS, Cho YJ, Kwon SU, Kim SE, Park SH. Acta Neurol Scand. 2010 Jan;121(1):51-7.
36. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Hong KS, Saver JL. Stroke. 2009 Dec;40(12):3828-33.
37. Intravenous recombinant tissue plasminogen activator thrombolysis in a patient with acute ischemic stroke secondary to aortic dissection. Hong KS, Park SY, Whang SI, Seo SY, Lee DH, Kim HJ, Cho JY, Cho YJ, Jang WI, Kim CY. J Clin Neurol. 2009 Mar;5(1):49-52.
38. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, Park JM, Bae HJ, Lee BC. Eur J Neurol. 2008 Dec;15(12):1324-31.
39. Diffusion changes suggesting vasogenic edema during partial status epilepticus. Keun-Sik Hong, Yong-Jin Cho, Sang Kun Lee, Sang-Wuk Jeong, Kwon-kyoo Kim, Eun-Jin Oh. Seizure 2004:13;317-321.
40. Pre-surgical uation and surgical outcome of 41 patients with non-lesional neocortical epilepsy. Keun-Sik Hong, Sang Kun Lee, Joo-Yong Kim, Dong-Soo Lee, Chun-kee Chung. Seizure 2002;11:184-192.
41. Diffusion-weighted magnetic resonance imaging in Wernicke's encephalopathy. Keun-Sik Hong, Dong-Wha Kang, Yong-Jin Cho, Yoon-Joon Hwang, Gham Hur. Acta Neurol Scand 2002:105;132-134.
42. Visual working memory revealed by repetitive transcranial magnetic stimulation. Keun-Sik Hong, Sang Kun Lee, Joo-Yong Kim, Kwang-Ki Kim, Hyunwoo Nam. Journal of the Neurological Sciences 2000;181:50-55.